SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-136205
Filing Date
2020-05-07
Accepted
2020-05-07 16:03:09
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d907899d10q.htm 10-Q 965686
2 EX-10.1 d907899dex101.htm EX-10.1 49202
3 EX-31.1 d907899dex311.htm EX-31.1 11265
4 EX-31.2 d907899dex312.htm EX-31.2 11247
5 EX-32.1 d907899dex321.htm EX-32.1 4650
6 EX-32.2 d907899dex322.htm EX-32.2 4679
  Complete submission text file 0001193125-20-136205.txt   5137135

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tbio-20190331.xml EX-101.INS 996846
8 XBRL TAXONOMY EXTENSION SCHEMA tbio-20190331.xsd EX-101.SCH 50876
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20190331_cal.xml EX-101.CAL 34325
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20190331_def.xml EX-101.DEF 258212
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20190331_lab.xml EX-101.LAB 430413
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20190331_pre.xml EX-101.PRE 356135
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 20856218
SIC: 2836 Biological Products, (No Diagnostic Substances)